Medical and Scientific Translation Across Canada Contact us Français

Home/Documents/Clinical Study Report Translation

Clinical Study Report Translation

Mediwords translates clinical study reports, synopses, patient narratives and lay summaries for sponsors, CROs and academic research teams. Specialized native-language medical translators work on the agreed text, tables and appendices; independent linguistic revision checks translated content and numerical references against the source.

Get a quote
  • ICH E3 structure
  • Source-value checks
  • Lay summaries
Medical writer reviewing a translated clinical study report with statistical tables

Trusted by healthcare and life sciences organizations

  • Dexcom logo, client of Mediwords
  • Canadian Cancer Society logo, client of Mediwords
  • Allianz logo, client of Mediwords
  • Sun Life logo, client of Mediwords
  • YMCA New Brunswick logo, client of Mediwords
  • Sinai Health logo, client of Mediwords

Translating Clinical Study Reports with Scientific Accuracy

Clinical study reports (CSRs) bring together the methods, conduct, efficacy findings and safety results of a clinical study. Mediwords translates complete CSRs, study synopses, patient narratives and selected sections for pharmaceutical sponsors, CROs and research organizations. Our work preserves clinical and statistical meaning, document structure and source data so international reviewers and partners can evaluate the same study information across languages.

A CSR can span several hundred pages, including detailed statistical analyses, patient narratives, tables and appendices. Translation requires careful control of terminology and references, but does not replace the sponsor’s scientific or regulatory review.

We handle CSRs within our clinical trial translation services, using the approved study terminology and relevant protocol references. For study protocols and amendments prepared before or during a trial, see our clinical trial protocol translation service. This page focuses on completed study reports, analysis results, patient narratives and supporting appendices.

When a CSR or Its Synopsis Is Translated

Submissions abroad

A report written in English may need another language for a regulator or partner in another country, or a report written in another language may need an English version.

Licensing and partnerships

Partners evaluating a product in another market often ask for the CSR or its synopsis in their language.

Academic studies

Investigator-initiated studies written in French need an English report for international funders, partners or publication.

Synopses

The synopsis is the most frequently translated part, for registries, committees, investigators and partners.

Patient narratives

Narratives of serious adverse events and deaths are sometimes requested separately, in the language of the reviewer.

Lay summaries

Summaries of results written for participants and the public, translated into the languages of the people who took part.

English and Canadian French are among our principal language combinations, but Mediwords also supports clinical study report translation in more than 30 languages. We work with sponsors and research organizations translating reports, synopses and selected study results for international partners and markets, using specialized native-language translators and shared study terminology.

The ICH E3 Structure, Section by Section

The ICH E3 guideline on the structure and content of clinical study reports provides an internationally recognized framework. We follow each source report’s approved organization and terminology, paying particular attention to synopses, study populations, efficacy analyses, safety results, statistical tables and appendices. We preserve the scientific meaning and document references; scientific validity and regulatory acceptance remain the sponsor’s and authorities’ responsibilities.

SectionWhat we check
SynopsisAccurately reflects the study design, populations, endpoints and key findings reported in the full CSR, without introducing inconsistencies
Ethics and investigatorsNames, institutions and ethics statements reproduced exactly
Introduction, objectives and investigational planSame wording as the protocol translation for design, endpoints and populations
Study patientsDisposition, protocol deviations and demographics, with every count and percentage verified
Efficacy evaluationStatistical terms, confidence intervals, p-values and analysis populations kept exact
Safety evaluationPreserves adverse event terminology and source findings, using the sponsor’s approved vocabulary and MedDRA terminology where applicable
Discussion and conclusionsNo softening or strengthening of the conclusions
Tables, figures and appendicesHeaders, footnotes and legends translated, values checked, structure unchanged

Numbers, Tables and Narratives

Clinical study reports contain extensive numerical and statistical information, including efficacy outcomes, safety findings, confidence intervals, p-values and subgroup analyses. Our linguistic revision checks translated table headings, labels, footnotes, units, numerical values and cross-references against the approved source files. We preserve the meaning of statistical conclusions without recalculating results or independently validating the underlying clinical data.

Patient narratives require particular attention to dates, doses, laboratory values and outcomes. We use approved terminology consistent with the adverse event reports and available study references, while flagging discrepancies for the sponsor’s review rather than modifying source data.

Clinical Information Made Public in Canada

Health Canada’s Public Release of Clinical Information (PRCI) initiative provides access to eligible clinical information from drug submissions and medical device applications following regulatory review. Clinical study reports may form part of the information released, subject to applicable anonymization, redaction and confidentiality requirements.

For sponsors preparing multilingual study documentation, consistency between the CSR, synopsis and related regulatory materials is important. Mediwords supports the linguistic accuracy of these documents, while decisions about disclosure eligibility, anonymization, redaction and regulatory submission remain with the sponsor and the relevant authorities. Our regulatory translation services support related submission documents.

Lay Summaries of Results

Lay summaries communicate clinical study results to participants and non-specialist readers using accessible, non-promotional language. Unlike the technical CSR, they explain the study’s purpose, methods, main findings and safety information without requiring specialist medical knowledge.

Mediwords translates these summaries with attention to readability, approved terminology and numerical consistency. We can draw on the study’s informed consent vocabulary where appropriate, while the sponsor remains responsible for scientific approval and applicable disclosure requirements.

From Report to Publication

Results reported in a CSR often become a journal article, a congress abstract or a poster. When the same results are published in another language, we reuse the approved terminology of the report so the article and the CSR describe the study the same way. Our medical publication translation team handles manuscripts, abstracts and responses to reviewers.

The Language of Statistics

Results sections are written in a precise statistical vocabulary: least squares means, hazard ratios, non-inferiority margins, per-protocol and full analysis sets. Each term has an established equivalent, and a loose translation can change what a result appears to show. Our translators use the standard terms of the target language and keep the structure of each statistical statement.

Number formats vary between languages. Canadian French often uses a decimal comma and spaces for grouping digits. Before translation, we agree whether tables should retain the source notation or follow target-language conventions; any approved formatting changes are checked against source values and must never alter the underlying numerical data.

Who Sends Us Clinical Study Reports

  • Pharmaceutical and biotech sponsors: reports and synopses for submissions and partners in other countries
  • CROs: reports prepared for sponsors, often with tight submission timelines
  • Academic research teams: reports of investigator-initiated studies for funders and international partners
  • Medical device manufacturers: clinical investigation reports for device applications

How We Translate Clinical Study Reports

Our ISO 17100-aligned process, adapted to CSRs:

  1. Preparation. We review the report, the protocol translation and your terminology, and plan the work by section for long reports.
  2. Translation. Native medical translators with clinical research experience translate the text, tables and appendices with one glossary.
  3. Revision. A second medical translator checks every section and table against the source.
  4. Final check. The project manager verifies numbers, cross-references, numbering and formatting.
  5. Delivery. You receive the report in its original format, with a certificate of accuracy on request.

For large clinical study reports, we agree on the translation scope before work begins, including which tables, listings, appendices and supporting files are included. We coordinate terminology across assigned linguists, preserve available document identifiers and cross-references, and can deliver approved sections in stages. When revised source files are provided, we identify affected passages for translation and review, helping your document control team maintain consistency between versions.

What to Send Us for an Accurate Quote

  • The report: the full CSR or the parts you need translated, in Word if possible
  • Tables and appendices: in their native format, so we can tell you which parts need translation
  • Reference translations: the translated protocol, consent form or earlier reports for the same product
  • Target languages: and the purpose of the translation
  • Your deadline: including any submission or partner date

With these, we send a fixed price and a delivery date within one business day.

Clinical Study Report Translation FAQ

Do you translate full CSRs or only synopses?

Both. Many sponsors need only the synopsis or selected sections. We quote the full report and each partial option so you can choose.

Do you translate tables, listings and appendices?

Yes. We translate the tables, listings and appendices included in the agreed project scope, preserving their headings, labels, notes and references. Numerical values are checked against the source, but we do not recalculate or independently validate study results. Your team determines which supporting materials are required for the intended submission or review.

How do you keep the CSR consistent with the protocol?

We use the approved study glossary, protocol translation and available reference documents to maintain consistent terminology for study design, endpoints, analysis populations and treatment groups. Any apparent inconsistencies between the source CSR and protocol are flagged for your team’s review rather than silently corrected.

Can you translate patient narratives separately?

Yes. Narratives can be translated as a separate set, with the terminology of your safety database.

Do you translate lay summaries of results?

Yes. We translate lay summaries in plain language for participants, in the languages of the people who took part.

Who translates clinical study reports?

Native medical translators with clinical research and statistics experience, followed by a second medical translator who revises the full report.

Can several translators work on a long report?

Yes. Large CSRs can be divided into coordinated work packages, with specialized translators sharing approved terminology and reference files. Independent linguistic revision and final consistency checks help maintain coherence across sections, tables and appendices. The delivery schedule is agreed according to document volume, languages and complexity.

Do you sign NDAs before receiving a report?

Yes. We can sign your non-disclosure agreement before you send any file.

Do you keep the decimal format of the source tables?

We agree on the number format with you at the start. Tables can keep the source format or follow the conventions of the target language, and the same rule is applied throughout the report.

Get a Quote for Your Study Report

Send us your report or the sections you need, with the target languages and your deadline. We reply within one business day with a fixed price and a delivery date. You can also write to us at info@mediwords.ca.